Top 50 Stocks
November 29, 2023 | Daily JAM, Jubak Picks, Top 50 Stocks |
At least the hand-over-fist selling of lithium stocks stopped for a day. Albemarle (ALB), the big and low-cost producer, did experience another 0.43% drop today, November 29. But that was still way better than the 6.3% plunge on Monday. And shares of Lithium Americas (LAC) and qm (SQM) managed gains of 1.38% and 0.98%, respectively. There’s no mystery to the drop. Lithium prices have continued to fall. As o Monday, Chinese prices for lithium carbonate have dropped 20% so far in November and 75% for 2023 to date.
November 21, 2023 | AAPL, AMZN, Daily JAM, GOOG, Jubak Picks, MSFT, NVDA, Top 50 Stocks, TSLA |
On Monday Nvidia (NVDA) hit an all-time high. For 2023 through November 17, Nvidia and the other 6 stocks in the Magnificent Seven–Apple (AAPL), Alphabet (GOOG), Microsoft (MSFT), Amazon (AMZN), Meta (META), and Tesla (TSLA)–have gained more than 70%. The other 493 stocks in the Standard & Poor’ 500 are up 6% for that same period.
November 18, 2023 | Daily JAM, NVDA, Short Term, Stock Alerts, Top 50 Stocks, TSM |
Nvidia’ earnings report after the close on Tuesday, November 21, will be the big event of the short Thanksgiving week.
November 16, 2023 | Daily JAM, Long Term, Millennial, Top 50 Stocks |
More real world dissent to Wall Street’s view that everything looks great for 2024. On Thursday Cisco Systems (CSCO) shares closed down 9.83% after the networking giant offered up significantly weaker-than-expected guidance for 2024. Wall Street analysts called the guidance “disappointing.” And the same day cybersecurity favorite Palo Alto Networks (PANW) dropped 5.42% after the company lowered its billings forecast for the fiscal 2024 year.
November 2, 2023 | AAPL, Daily JAM, Long Term, Morning Briefing, Top 50 Stocks |
So let’s see how the market takes this tomorrow.
Today stocks staged an impressive upside more. The Standard & Poor’s 500 closed up 1.89% and the NASDAQ Composite ended the day 1.78% higher. The small cap Russell 2000 was the day’s best performer with a win of 2.67% Tomorrow? Well, the October jobs report released at 8:30 will certainly help set the tone for the day with a weak report likely to reinforce the belief that the Federal Reserve is done aiding interest rates. But given how much of the recent bounce has been fueled by a return of optimism about technology stocks, it’s likely that Apple’s disappointing results, announced after the close of trading today, Thursday, November 2, will determine the direction of the trend.
October 30, 2023 | BHP, CAT, Daily JAM, DE, Dividend Income, Jubak Picks, Special Reports, Top 50 Stocks |
Today I posted Step #8 in my Special Report: 8 Steps to Protect Your Portfolio from the Global Debt Bomb. I recommended selling Deere (DE), Caterpillar (CAT), and BHP Group (BHP) out of portfolios ahead of rising yields i the bond market. (In the case of Deere, I said I would keep my position in my long-term portfolio but sell the position in my 12-18 month portfolio.) Here’s what I posted in my Special Report
October 27, 2023 | AMZN, Daily JAM, INTC, Short Term, Top 50 Stocks, VIX, Volatility |
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...
October 24, 2023 | AAPL, ALB, CAT, Daily JAM, DE, Dividend Income, DUK, F, GM, Jubak Picks, Mid Term, NI, SCCO, Short Term, Special Reports, Top 50 Stocks |
I’ve hi-lighted the key characteristics of the coming global debt bomb explosion that investors MUST include in any plan to protect a portfolio from the explosion of this bomb.
October 22, 2023 | AMZN, Daily JAM, Dividend Income, GOOG, Jubak Picks, KMB, KO, MSFT, Top 50 Stocks, XOM |
Investors see a ton of third-quarter earnings reports this coming week with news from Microsoft, Amazon, Meta Platforms, and Alphabet quite capable of moving the entire market. We’ll also get more consumer company (Coca-Cola and Kimberly-Clark for example) reports to show whether last week’s higher revenue but lower volume pattern continues. And Wall Street is expecting negative new from oil companies ExxonMobil (XOM) and Chevron (CVX) when they both report on Friday.
September 21, 2023 | AAPL, AMZN, Daily JAM, Morning Briefing, NVDA, Top 50 Stocks, Volatility |
Now that Fed day is done and behind us, we return to our regularly scheduled programming. Back on September 15, I posted “A tough day for tech–Part 1” after news on Taiwan Semiconductor Manufacturing (TSM) reporting that the company was slowing orders with suppliers of chip making equipment because of sluggish demand for chips from its customers. Now onto Part 2 of bad news for tech stocks.
September 14, 2023 | Daily JAM, Dividend Income, Jubak Picks, Mid Term, SCCO, Top 50 Stocks |
The People’s Bank of China cut the amount of cash banks must hold in reserve for the second time this year. The move is an effort to boost flagging economic growth in China. The bank could have cut its benchmark interest rate in pursuit of the same goal. But that would have led to more selling against the yuan and the People’s Bank has been busy in the trenches in recent weeks trying to prop up the yuan agains the dollar. The question, of course, is whether the cut in reserve requirements will be enough, without a reduction in interest rates, to revive growth in China’s economy.
August 19, 2023 | Daily JAM, Jubak Picks, Top 50 Stocks, Videos |
Today’s Quick Pick is Eli Lilly And Co (LLY). Lilly is my favorite big drug stock right now. The company recently announced second-quarter earnings and showed 22% year-over-year sales growth. The company has a promising pipeline of new drugs. Mounjaro, Lilly’s diabetes drug, is likely to get weight-loss approval from the FDA. They also have new products for Alzheimers, and Cardio Metabolic drugs coming out soon. The growing enthusiasm for diabetes and weight-loss drugs has the stock overvalued by about 46% according to Morningstar. Their competitors are in similar situations. Novo Nordisk (NVO) is 28% overvalued according to Morningstar. At this point, if you’re looking for somewhere to immediately put some money to work, I’d still go with Eli Lilly. In this case, you have to consider not just the absolute valuation but also weigh the prospects of both companies. In my opinion, Eli Lilly outshines Novo Nordisk if you look at the pipelines at the two companies
